T cell exhaustion in malignant gliomas: Trends in Cancer
TIM‐3 as a potential exhaustion marker in CD4+ T cells of COVID‐19 patients - Modabber - 2021 - Immunity, Inflammation and Disease - Wiley Online Library
Tim-3 co-stimulation promotes short-term effector T cells, restricts memory precursors and is dispensable for T cell exhaustion | bioRxiv
Frontiers | Use of Mass Cytometry to Profile Human T Cell Exhaustion
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection | PLOS Pathogens
Frontiers | Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy
Tim-3 finds its place in the cancer immunotherapy landscape | Journal for ImmunoTherapy of Cancer
T Cell Exhaustion Infographic - Enzo Life Sciences
TIM-3, a Possible Target for Immunotherapy in Cancer and Chronic Viral Infections
Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion - eBioMedicine
IJMS | Free Full-Text | Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion
Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion | PNAS
Expression of CD8 + T cell exhaustion markers PD1, TIM3, and LAG3 in... | Download Scientific Diagram
The CAR T cell expression of exhaustion markers. PD-1 (A), TIM-3 (B) or... | Download Scientific Diagram
Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C | Scientific Reports
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection | PNAS
Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion | PNAS